GENENTECH INC.

Company Snapshot

Founded: 1976
Entity Type: Private
Employees: 13,500
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.
Corporate Address: 1 DNA Way Mailstop 258A, South San Francisco, California 94080 U.S. Tel. +1-650-225-1000 www.gene.com

Company Overview

Genentech is a biotechnology company dedicated towards discovering and developing medicines for people with severe and life-threatening disease indications. Roche acquired Genentech in March 2009 and combined all the pharma operations under the wider biopharmaceutical business. The company's key drug discoveries include the first medicine for primary progressive multiple sclerosis and the first targeted antibody for cancer.

The key focus areas include oncology, immunology, neuroscience, metabolism, infectious disease, ophthalmology and more. As of now, there are more than 50 drugs in the pipeline.

GENENTECH INC. In Reports

mRNA: Therapeutics and Global Markets

BCC Research Market Report says mRNA therapeutics should grow from $46.7 billion in 2021 to $101.3 billion by 2026, at compound annual growth rate of 16.8%

Global Markets and Technologies for Advanced Drug Delivery Systems

An overview of the global markets and technologies for advanced drug delivery systems

Chronic Kidney Disease: Global Markets and Technologies Through 2023

According to BCC Research global market for chronic kidney disease should grow from $79.0 billion in 2018 to reach $95.0 billion by 2023 at a compound annual growth rate of 3.8%.

Applications/End User Industries

  • Oncology
  • Immunology
  • Infectious Diseases
  • Neuroscience
  • Ophthalmology
  • Clinical Trials
  • Healthcare Professionals
  • Medical Trial
  • Physician
AI Sentiment